Please use this identifier to cite or link to this item:
Title: Evaluation of family health history collection methods impact on data and risk assessment outcomes
Authors: Wu, R.R.
Sultana, R.
Bylstra, Y.
Jamuar, S. 
Davila, S. 
Lim, W.K. 
Ginsburg, G.S.
Orlando, L.A.
Yeo, K.K. 
Cook, S.A. 
Tan, P. 
Keywords: Data accuracy
Family health history
Health risk assessment
Preventive health services
Issue Date: 2020
Publisher: Elsevier Inc.
Citation: Wu, R.R., Sultana, R., Bylstra, Y., Jamuar, S., Davila, S., Lim, W.K., Ginsburg, G.S., Orlando, L.A., Yeo, K.K., Cook, S.A., Tan, P. (2020). Evaluation of family health history collection methods impact on data and risk assessment outcomes. Preventive Medicine Reports 18 : 101072. ScholarBank@NUS Repository.
Rights: Attribution-NonCommercial-NoDerivatives 4.0 International
Abstract: Information technology applications for patient-collection of family health history (FHH) increase identification of elevated-risk individuals compared to usual care. It is unknown if the method of collection impacts data collected or if simply going directly to the patient is what makes the difference. The objective of this study was to examine differences in data detail and risk identification rates between FHH collection directly from individuals using paper-based forms and an interactive web-based platform. This is a non-randomized epidemiologic study in Singaporean population from 2016 to 2018. Intervention was paper-based versus web-based interactive platform for FHH collection. Participant demographics, FHH detail, and risk assessment results were analyzed. 882 participants enrolled in the study, 481 in the paper-based group and 401 in the web-based group with mean (SD) age of 45.4 (12.98) years and 47.5% male. Web-based FHH collection participants had an increased number of conditions per relative (p-value <0.001), greater frequency of reporting age of onset (p-value <0.001), and greater odds of receiving ≥1 risk recommendation both overall (OR: 3.99 (2.41, 6.59)) and within subcategories of genetic counselling for hereditary cancer syndromes (p-value = 0.041) and screening and prevention for breast (p-value = 0.002) and colon cancer (p-value = 0.005). This has significant implications for clinical care and research efforts where FHH is being assessed. Using interactive information technology platforms to collect FHH can improve the completeness of the data collected and result in increased rates of risk identification. Methods of data collection to maximize benefit should be taken into account in future studies and clinical care. © 2020
Source Title: Preventive Medicine Reports
ISSN: 22113355
DOI: 10.1016/j.pmedr.2020.101072
Rights: Attribution-NonCommercial-NoDerivatives 4.0 International
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1016_j_pmedr_2020_101072.pdf196.75 kBAdobe PDF



Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons